China Shineway Pharmaceutical Group Limited Share Price
Stocks
2877
KYG2110P1000
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
09:08:08 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 8.060 HKD | -1.59% |
|
+0.12% | -6.28% |
| 05-07 | China Shineway Pharmaceutical's Turnover Slides 18% in Q1 | MT |
| 05-07 | China Shineway Pharmaceutical posts Q1 turnover of RMB624 mln | RE |
| Market Cap | 5.22B 6.09B 777M 665M 622M 570M 1.07B 74.3B 1.08B 7.35B 2.87B 37.33B 2.92B 2.85B 123B | P/E 2026 * |
5.46x | P/E 2027 * | 4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 5.22B 6.09B 777M 665M 622M 570M 1.07B 74.3B 1.08B 7.35B 2.87B 37.33B 2.92B 2.85B 123B | EV / Sales 2026 * |
1.72x | EV / Sales 2027 * | 1.6x |
| Free-Float |
33.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.59% | ||
| 1 week | +0.12% | ||
| Current month | -1.23% | ||
| 1 month | -2.18% | ||
| 3 months | -4.39% | ||
| 6 months | -15.69% | ||
| Current year | -6.28% |
| 1 week | 7.96 |  | 8.35 |
| 1 month | 7.9 | | 8.46 |
| Current year | 7.21 | | 10.47 |
| 1 year | 7.21 | | 10.47 |
| 3 years | 6.55 | | 10.76 |
| 5 years | 4.63 | | 10.76 |
| 10 years | 4.6 | | 18.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
King Kuen Hung
IRC | Investor Relations Contact | 60 | - |
Baochang Liu
SAM | Sales & Marketing | 46 | 30/11/2019 |
Bun Ching Lee
AUD | Comptroller/Controller/Auditor | 53 | 31/01/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhen Jiang Li
CHM | Chairman | 70 | 13/08/2002 |
Yun Xia Xin
BRD | Director/Board Member | 62 | 13/08/2002 |
Hui Min Li
BRD | Director/Board Member | 58 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/10/22 | Other | Director | 280,000 | 0.0339% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.59% | +0.12% | -3.12% | +11.94% | 777M | |
| -0.08% | -1.43% | +15.87% | +67.24% | 47.71B | |
| -3.21% | +1.37% | +51.19% | +124.26% | 40.3B | |
| -0.40% | -1.23% | -10.08% | +17.30% | 12.09B | |
| +1.11% | -1.34% | +13.27% | +72.07% | 11.68B | |
| +0.19% | +0.58% | +30.98% | +151.21% | 9.19B | |
| -0.39% | -0.92% | +20.49% | +39.85% | 7.57B | |
| -1.35% | +0.74% | +47.38% | -12.13% | 7.24B | |
| -0.64% | -0.02% | +19.65% | +205.39% | 6.84B | |
| -5.36% | -6.36% | -38.04% | +19.49% | 5.42B | |
| Average | -1.17% | -0.99% | +14.76% | +69.66% | 14.88B | |
| Weighted average by Cap. | -1.15% | -0.57% | +23.94% | +83.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.03B 3.54B 451M 387M 362M 331M 621M 43.18B 630M 4.27B 1.67B 21.69B 1.69B 1.66B 71.75B | 3.26B 3.81B 485M 416M 389M 356M 668M 46.44B 677M 4.6B 1.79B 23.33B 1.82B 1.78B 77.17B |
| Net income | 956M 1.11B 142M 122M 114M 104M 196M 13.61B 198M 1.35B 525M 6.83B 534M 522M 22.61B | 1.07B 1.25B 159M 137M 128M 117M 220M 15.26B 222M 1.51B 589M 7.66B 599M 586M 25.35B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | HK$8.060 | -1.59% | 302,000 |
| 20/08/26 | HK$8.190 | +2.44% | 566,000 |
| 19/08/26 | HK$7.995 | -0.81% | 595,000 |
| 18/08/26 | HK$8.060 | +0.31% | 427,000 |
| 17/08/26 | HK$8.035 | -0.19% | 325,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2877 Stock
Select your edition
All financial news and data tailored to specific country editions
